The 61 rating Investors Observer indicates the shares of Meridian Bioscience, Inc. (VIVO) and places it near the top of the Diagnostics & Research industry. In addition to scoring higher than 88 percent of the Diagnostics & Research industry stock, VIVO’s overall rating of 61 means the stock outperforms 61 percent of all stocks.
What do these ratings mean?
Analyzing stocks can be difficult. There are countless numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. Investors Observer ranks stocks on eight different metrics. We rank most of our scores by percentiles to make it easy for investors to understand. A score of 61 means the stock is more attractive than 61 percent of the stock. Our proprietary scoring system captures technical factors, fundamental analysis and the views of Wall Street analysts. This makes Investors Observer‘s overall rating is a great way to get started, whatever your investment style. Percentile ranked scores are also easy to understand. A score of 100 is the highest and a 0 is the lowest. No need to try to remember what is “good” for some complicated ratios, just pay attention to which numbers are the highest.
The share of Meridian Bioscience, Inc. (VIVO) is trading at $31.95 as of 2:35 PM on Wednesday, November 23, up $0.17 or 0.55% from its previous close of $31.77. The stock has traded between $31.72 and $32.00 so far. Volume is low today. So far, 62,902 shares have been traded compared to an average volume of 290,559 shares. Click here for the full stock report for Meridian Bioscience, Inc. shares.
Subscribe to our daily morning update newsletter and never miss the most important market news, movements and more.